#NewAseBioMember | “This partnership gives us the possibility to establish key contacts an... 20/05/2024 Healthcare Access to innovation Innovative drugs Personalized medicine Advanced therapies Meet Kirsch Pharma, our new member. We talked to its Raquel Márquez Duro, Key Account Mánager de España y Portugal. AseBio - Kirsch Pharma España
Mikrobiomik launches strategic investment round to advance its first medicine based on the... 30/04/2024 Healthcare Drug discovery Rare diseases Innovative drugs The Biscayan biopharmaceutical company, which plans to launch its first biological medicine into the market in the first... Partners - Mikrobiomik
Creation of new 3D liver cell models for research 30/04/2024 Healthcare Access to innovation Innovative drugs Personalized medicine Advanced therapies The main objective of the project is the creation of innovative in vitro models using microencapsulation of human liver... Partners - BeCytes Biotechnologies
The synergy between biotechnology and immunology catalyzes the development of more effecti... 29/04/2024 Healthcare Drug discovery Innovative drugs Personalized medicine Advanced therapies Biotechnology has achieved significant advances in diagnosis and precision therapies, the production of biotechnological... AseBio
The synergy between biotechnology and immunology catalyzes the development of more effecti... 29/04/2024 Biotechnology has achieved significant advances in diagnosis and precision therapies, the production of biotechnological... AseBio
Biotechnology and DNA: The duo paving the way for the era of customization in health and a... 25/04/2024 Healthcare Access to innovation Innovative drugs Personalized medicine Agrifood Food & feed Gene editing Next-generation DNA sequencing has a significant impact on personalized medicine, genomic research, and the... AseBio
MATCH Biosystems, MIKROBIOMIK, and Oniria Therapeutics have been selected for the second e... 24/04/2024 Healthcare Access to innovation In vitro diagnostics Innovative drugs Personalized medicine The three companies, members of AseBio, work every day to improve treatments and patients' lives through rapid diagnosis... AseBio
ORYZON secures another important patent for its lead CNS asset, vafidemstat 22/04/2024 Healthcare Drug discovery Innovative drugs Advanced therapies Has received “Intention to Grant” from the European Patent Office. Partners - Oryzon Genomics
The "yes" from the European Parliament to the reform of pharmaceutical legislation jeopard... 12/04/2024 Healthcare Access to innovation Drug discovery Innovative drugs Personalized medicine Advanced therapies Antibiotic resistance Biotechnology has radically transformed the discovery of new drugs: 68% of the drugs currently in development globally... AseBio
The "yes" from the European Parliament to the reform of pharmaceutical legislation jeopard... 12/04/2024 We consider that improvements have been made regarding the original proposal, but these continue to be insufficient for... AseBio
